Amylyx Pharmaceuticals Announces Publication Of Data Showing The Effect Of AMX0035 On Plasma Neuroinflammatory Biomarkers In ALS
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) ("Amylyx" or the "Company") today announced the publication of analyses performed on neuroinflammatory biomarkers using plasma samples from participants with amyotrophic lateral